Patents-Review.com
🔗 Permalink
Assignee profile:

Acceleron Pharma Inc.

City:

Rahway, New Jersey

Country:

United States

Published Applications:

14

Last publication date:

2025-12-04

Patent Grants:

7

Last grant date:

2025-09-23

Top Inventors for applications by Acceleron Pharma Inc.

These are the the leading inventors for applications assigned to Acceleron Pharma Inc.:

Recent patent applications by Acceleron Pharma Inc.

Acceleron Pharma Inc. based in Rahway, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-12-04
US20250368720A1
Chemistry; metallurgy

TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AND USES THEREOF

 #2 | 2025-10-30
US20250333477A1
Chemistry; metallurgy

NOVEL BINDERS OF TGFB-SUPERFAMILY LIGANDS AND USES THEREOF

 #3 | 2025-02-27
US20250066488A1
Chemistry; metallurgy

ACTRIIB BINDING AGENTS AND USES THEREOF

 #4 | 2025-02-27
US20250064952A1
Human necessities

ACTRII-ALK4 ANTAGONISTS AND METHODS OF TREATING HEART FAILURE

 #5 | 2024-09-19
US20240309098A1
Chemistry; metallurgy

ALK7 ANTAGONISTS AND USES THEREOF

 #6 | 2024-06-20
US20240197902A1
Human necessities

ACTRII-ALK4 ANTAGONISTS AND METHODS OF TREATING HEART FAILURE

 #7 | 2024-06-13
US20240189391A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING SPINAL MUSCULAR ATROPHY

 #8 | 2023-08-24 ✅ Patent 12,421,295 granted on 2025-09-23
US20230265161A1
Chemistry; metallurgy

TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AND USES THEREOF

 #9 | 2022-11-03 ✅ Patent 12,365,736 granted on 2025-07-22
US20220348685A1
Chemistry; metallurgy

ALK7 BINDING PROTEINS AND USES THEREOF

 #10 | 2022-09-22 ✅ Patent 12,144,860 granted on 2024-11-19
US20220296708A1
Human necessities

ALK1 receptor and ligand antagonists and uses thereof

 #11 | 2022-08-04 ✅ Patent 12,545,736 granted on 2026-02-10
US20220242956A1
Chemistry; metallurgy

ACTRII-BINDING PROTEINS AND USES THEREOF

 #12 | 2022-07-07 ✅ Patent 12,364,736 granted on 2025-07-22
US20220211805A1
Human necessities

METHODS FOR TREATING HETEROTOPIC OSSIFICATION

 #13 | 2022-03-24 ✅ Patent 11,857,599 granted on 2024-01-02
US20220088142A1
Human necessities

Compositions and methods for treating spinal muscular atrophy

 #14 | 2021-12-09 ✅ Patent 12,168,683 granted on 2024-12-17
US20210380663A1
Chemistry; metallurgy

Binders of TGFβ-superfamily ligands and uses thereof

Also check out Acceleron Pharma Inc.'s (Rahway, United States) applicant profile with 8 patent applications submitted.

AssigneeID:

348756 ⎘